LGT Fund Management Co Ltd. Buys 1,032 Shares of Colgate-Palmolive (NYSE:CL)

LGT Fund Management Co Ltd. raised its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 13.9% during the second quarter, HoldingsChannel reports. The fund owned 8,457 shares of the company’s stock after acquiring an additional 1,032 shares during the quarter. LGT Fund Management Co Ltd.’s holdings in Colgate-Palmolive were worth $821,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Mitchell Sinkler & Starr PA grew its stake in Colgate-Palmolive by 92.6% in the 4th quarter. Mitchell Sinkler & Starr PA now owns 45,899 shares of the company’s stock worth $3,659,000 after acquiring an additional 22,073 shares in the last quarter. Stonehage Fleming Financial Services Holdings Ltd grew its stake in Colgate-Palmolive by 57.1% in the fourth quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock valued at $30,594,000 after purchasing an additional 139,429 shares during the last quarter. D L Carlson Investment Group Inc. bought a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $3,269,000. Diversify Advisory Services LLC acquired a new position in shares of Colgate-Palmolive during the first quarter worth $911,000. Finally, TD Asset Management Inc increased its position in Colgate-Palmolive by 2.4% during the 1st quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock valued at $103,969,000 after buying an additional 26,987 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the transaction, the executive vice president now owns 10,377 shares in the company, valued at approximately $1,069,868.70. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. The disclosure for this sale can be found here. In the last quarter, insiders sold 43,490 shares of company stock valued at $4,486,063. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE:CL opened at $106.84 on Wednesday. The firm has a market cap of $87.30 billion, a P/E ratio of 33.81, a price-to-earnings-growth ratio of 3.78 and a beta of 0.40. The stock has a 50 day moving average of $101.52 and a two-hundred day moving average of $94.88. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $109.30. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. During the same period in the prior year, the company earned $0.77 EPS. The firm’s revenue was up 4.9% compared to the same quarter last year. On average, analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were given a dividend of $0.50 per share. The ex-dividend date was Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a yield of 1.87%. Colgate-Palmolive’s payout ratio is presently 63.29%.

Analysts Set New Price Targets

CL has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their target price for the stock from $107.00 to $109.00 in a research note on Monday. Stifel Nicolaus increased their price target on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, July 22nd. Citigroup boosted their price objective on Colgate-Palmolive from $103.00 to $112.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Wells Fargo & Company raised their target price on Colgate-Palmolive from $92.00 to $97.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 10th. Finally, Morgan Stanley boosted their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a report on Monday, July 29th. Nine research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $102.63.

View Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.